If you wish to apply to be lead plaintiff, please contact attorney Nicholas Bruno at (888) 398-9312 or at [email protected].

TransMedics Group (NASDAQ:TMDX – Get Free Report)‘s stock had its “buy” rating restated by Canaccord Genuity Group in a ...

New York, New York-- (Newsfile Corp. - March 13, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX) ...

It's been a rough several months for TransMedics Group (NASDAQ: TMDX) shareholders. The company's warm perfusion devices are ...

The Gross Law Firm issues the following notice to shareholders of TransMedics Group, Inc. . Shareholders who purchased shares of ...

TransMedics Group's organ care system can preserve multiple organs, but livers are responsible for 70% of total sales. OrganOx markets a normothermic machine perfusion device approved to preserve ...

SAN FRANCISCO, March 10, 2025 (GLOBE NEWSWIRE) -- A class-action lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX), a medical technology company specializing in organ ...

It's been a rough several months for TransMedics Group (NASDAQ: TMDX) shareholders. The stock has been beaten down by about 62% from the peak it set last August. The company's warm perfusion ...

Levi & Korsinsky, LLP notifies investors in TransMedics Group, Inc. ("TransMedics" or the "Company") of a class action securities ...

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) TransMedics used kickbacks, fraudulent overbilling, and coercive tactics to generate ...

BNY Mellon Small Cap Growth Fund outperformed its benchmark, the Russell 2000 Growth Index during Q4 2024. Click here to read ...

The BNY Mellon Small/Mid Cap Growth Fund (Class A at NAV) returned 7.34%% during the fourth quarter of 2024. Click here to read the full commentary.